Pharma Marketing Network

MARCH 5, 2025

So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ? FDA Requirements for Drug Advertising Include Fair Balance: Ads must present risks and benefits equally (especially for branded drugs like Humira, Xarelto, or Ozempic ). blogs or webinars).

HIPAA 52

HIPAA Diabetes 52

Pharma Marketing Network

MARCH 5, 2025

With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Being present at the top of search results improves brand awareness. However, the landscape isnt simple.

HIPAA 52

HIPAA Diabetes Hospitals 52

Pharma Marketing Network

FEBRUARY 19, 2025

Challenges in Pharma Email Marketing Pharma brands face unique barriers that other industries dont , such as: Strict compliance regulations (FDA, GDPR, HIPAA) that limit messaging. oncology, diabetes, cardiology). New Treatment Advances in Type 2 Diabetes). Email fatigue among HCPs and patients , leading to low open rates.

HIPAA 72

HIPAA Diabetes Labelling Communication 72

Pharma Marketing Network

MARCH 3, 2025

Challenges in Pharma CRO: Regulatory restrictions limit the way pharma brands present information. Example: A diabetes medication brand saw a 20% increase in prescription adherence after integrating a personalized patient support portal that provided reminder notifications, lifestyle tips, and digital refill assistance.

HIPAA 52

HIPAA Dosage Diabetes 52

Pharmaceutical Technology

JULY 1, 2022

A digital twin of the human body presents immense potential for the future of diagnostics. At this year’s American Diabetes Association annual scientific session, clinical trial data was presented that analysed 199 diabetes patients for an average of four years. Digital twins and healthcare data.

Health and Personal Care Stores 52

Health and Personal Care Stores Diabetes HIPAA Communication 52